Literature DB >> 16207661

Probiotics: a practical review of their role in specific clinical scenarios.

Barry Jenkins1, Steven Holsten, Stig Bengmark, Robert Martindale.   

Abstract

The use of probiotics (live viable microbial organisms) in the treatment of specific diseases has evolved into an extremely valuable option yet to be optimally used in clinical medicine. Probiotics have been shown to have immunomodulating properties and enhance the mucosal barrier. This review will briefly discuss the use of probiotics in inflammatory bowel disease, pancreatitis, liver transplantation, and various uses in diarrhea. When using probiotics, one must be cautious of the sometime overzealous claims that are commonly made when dealing with medical foods. As we begin to appreciate the degree of complexity that our indigenous microbial population has on health, it is only then that we can begin to understand the importance in disease. In the arena of probiotics, numerous fundamental questions remain unanswered.

Entities:  

Mesh:

Year:  2005        PMID: 16207661     DOI: 10.1177/0115426505020002262

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  3 in total

1.  Influences of enteral nutrition combined with probiotics on gut microflora and barrier function of rats with abdominal infection.

Authors:  Tong-Yi Shen; Huan-Long Qin; Zhi-Guang Gao; Xiao-Bing Fan; Xiao-Ming Hang; Yan-Qun Jiang
Journal:  World J Gastroenterol       Date:  2006-07-21       Impact factor: 5.742

2.  Natural health products, modulation of immune function and prevention of chronic diseases.

Authors:  Pierre S Haddad; Georges A Azar; Simon Groom; Michel Boivin
Journal:  Evid Based Complement Alternat Med       Date:  2005-10-20       Impact factor: 2.629

3.  Preventive role of probiotic bacteria against gastrointestinal diseases in mice caused by Giardia lamblia.

Authors:  Wafa A Al-Megrin; Shadia H Mohamed; Moudy M Saleh; Hany M Yehia
Journal:  Biosci Rep       Date:  2021-02-26       Impact factor: 3.976

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.